Israel Englander’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
PA
ACM
CM
CFM
CA
Israel Englander's NAUT Position: Q2 2026 in Review
Israel Englander reduced its Nautilus Biotechnolgy (NAUT) stake by 85% in Q2 2026, selling an estimated $2.86M and leaving 188,730 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #5023.
Israel Englander first reported a position in NAUT in Q3 2020 and has held it in 17 quarters since. The position peaked at $4.94M in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.
- Israel Englander held 188,730 shares of Nautilus Biotechnolgy worth $353K as of Q2 2026.
- Israel Englander sold 1,084,653 Nautilus Biotechnolgy shares in Q2 2026, an estimated $2.86M.
- Nautilus Biotechnolgy made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5023 holding.
- Israel Englander first reported a position in Nautilus Biotechnolgy in Q3 2020 and has held it in 17 quarters since.
- Israel Englander's Nautilus Biotechnolgy position peaked at $4.94M in Q1 2026.
- 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.